We've detected that Javascript is not enabled. It is required for an optimal survey taking experience.
Please check your browser's settings and make sure Javascript is turned on. Learn how to enable Javascript.

Skip survey header

Looking Beyond VEGF Suppression: Optimizing the Patient Journey

1. Please rate how well you think the session met the stated learning objectives below

At the end of this session, I am able to: *This question is required.

Space Cell	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Outline the role of the Tie-2/ang pathway in DR and nAMD and how it may impact patient outcomes	Outline the role of the Tie-2/ang pathway in DR and nAMD and how it may impact patient outcomes: Strongly disagree	Outline the role of the Tie-2/ang pathway in DR and nAMD and how it may impact patient outcomes: Disagree	Outline the role of the Tie-2/ang pathway in DR and nAMD and how it may impact patient outcomes: Neutral	Outline the role of the Tie-2/ang pathway in DR and nAMD and how it may impact patient outcomes: Agree	Outline the role of the Tie-2/ang pathway in DR and nAMD and how it may impact patient outcomes: Strongly agree
Identify the most important biomarkers on structural OCT that can help predict treatment response in DME and nAMD	Identify the most important biomarkers on structural OCT that can help predict treatment response in DME and nAMD: Strongly disagree	Identify the most important biomarkers on structural OCT that can help predict treatment response in DME and nAMD: Disagree	Identify the most important biomarkers on structural OCT that can help predict treatment response in DME and nAMD: Neutral	Identify the most important biomarkers on structural OCT that can help predict treatment response in DME and nAMD: Agree	Identify the most important biomarkers on structural OCT that can help predict treatment response in DME and nAMD: Strongly agree
Discuss real-world case presentations and when to switch patients from one agent to another	Discuss real-world case presentations and when to switch patients from one agent to another: Strongly disagree	Discuss real-world case presentations and when to switch patients from one agent to another: Disagree	Discuss real-world case presentations and when to switch patients from one agent to another: Neutral	Discuss real-world case presentations and when to switch patients from one agent to another: Agree	Discuss real-world case presentations and when to switch patients from one agent to another: Strongly agree
Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER)	Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER): Strongly disagree	Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER): Disagree	Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER): Neutral	Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER): Agree	Highlight reasons for the efficacy gap between clinical trials and real-world practice, and describe how to address that gap with improved real-world study design (eg, VOYAGER): Strongly agree

2. The session met the following CanMEDS roles: *This question is required.

Space Cell	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Medical Expert	Medical Expert: Strongly disagree	Medical Expert: Disagree	Medical Expert: Neutral	Medical Expert: Agree	Medical Expert: Strongly agree
Scholar	Scholar: Strongly disagree	Scholar: Disagree	Scholar: Neutral	Scholar: Agree	Scholar: Strongly agree

3. Based on this session, I will pursue additional learning on the following topics: *This question is required.

4. Based on this session, I will make the following changes to my practice: *This question is required.

5. Would you recommend this session topic for next year’s conference? Please explain : *This question is required.

6. Please rate the following statements: *This question is required.

Space Cell	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
The content was relevant to my learning needs	The content was relevant to my learning needs: Strongly disagree	The content was relevant to my learning needs: Disagree	The content was relevant to my learning needs: Neutral	The content was relevant to my learning needs: Agree	The content was relevant to my learning needs: Strongly agree
The teaching methods were effective	The teaching methods were effective: Strongly disagree	The teaching methods were effective: Disagree	The teaching methods were effective: Neutral	The teaching methods were effective: Agree	The teaching methods were effective: Strongly agree
There was adequate time for questions and answers	There was adequate time for questions and answers: Strongly disagree	There was adequate time for questions and answers: Disagree	There was adequate time for questions and answers: Neutral	There was adequate time for questions and answers: Agree	There was adequate time for questions and answers: Strongly agree
The session was a suitable length	The session was a suitable length: Strongly disagree	The session was a suitable length: Disagree	The session was a suitable length: Neutral	The session was a suitable length: Agree	The session was a suitable length: Strongly agree
The speakers were engaging	The speakers were engaging: Strongly disagree	The speakers were engaging: Disagree	The speakers were engaging: Neutral	The speakers were engaging: Agree	The speakers were engaging: Strongly agree
The presentations were non-biased	The presentations were non-biased: Strongly disagree	The presentations were non-biased: Disagree	The presentations were non-biased: Neutral	The presentations were non-biased: Agree	The presentations were non-biased: Strongly agree

If bias was perceived, please describe: *This question is required.

7. Additional comments: